Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 762 Lung Neoplasms 339 Ovarian Neoplasms 318 Breast Neoplasms 277 Fallopian Tube Neoplasms 158 Triple Negative Breast Neoplasms 143 Small Cell Lung Carcinoma 140 Neoplasms 134 Squamous Cell Carcinoma of Head and Neck 122 Carcinoma, Ovarian Epithelial 114 Neoplasm Metastasis 84 Head and Neck Neoplasms 80 Endometrial Neoplasms 76 Uterine Cervical Neoplasms 70 Esophageal Neoplasms 70 Adenocarcinoma of Lung 68 Neuroblastoma 55 Central Nervous System Neoplasms 52 Lymphoma, Large B-Cell, Diffuse 49 Carcinoma 49 Brain Neoplasms 48 Recurrence 47 Prostatic Neoplasms 44 Parkinson Disease 4, Autosomal Dominant Lewy Body 44 Urinary Bladder Neoplasms 42 Esophageal Squamous Cell Carcinoma 41 Lymphoma 39 Melanoma 35 Carcinoma, Squamous Cell 33 Lymphoma, Non-Hodgkin 31

Interventions

midostaurin 2 selinexor 1 pegfilgrastim 1 glofitamab 1 Topotecan 1 Rituximab 1 Prednisone 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Bexarotene 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Aggression × Carboplatin × Clear all

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡